Cited by 143Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsPhagocytosis and Immune Regulation

Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer’s disease pathology

Open access
Kummer, Markus P, Ising, Christina, Kummer, Christiane, Sarlus, Heela, Griep, Angelika, Vieira‐Saecker, Ana, Schwartz, Stephanie, Halle, Annett +6 more·2021·The EMBO Journal

Abstract

Chronic neuroinflammation is a pathogenic component of Alzheimer’s disease (AD) that may limit the ability of the brain to clear amyloid deposits and cellular debris. Tight control of the immune system is therefore key to sustain the ability of the brain to repair itself during homeostasis and disease. The immune‐cell checkpoint receptor/ligand pair PD‐1/PD‐L1, known for their inhibitory immune function, is expressed also in the brain. Here, we report upregulated expression of PD‐L1 and PD‐1 in astrocytes and microglia, respectively, surrounding amyloid plaques in AD patients and in the APP/PS1 AD mouse model. We observed juxtamembrane shedding of PD‐L1 from astrocytes, which may mediate ectodomain signaling to PD‐1‐expressing microglia. Deletion of microglial PD‐1 evoked an inflammatory response and compromised amyloid‐β peptide (Aβ) uptake. APP/PS1 mice deficient for PD‐1 exhibited increased deposition of Aβ, reduced microglial Aβ uptake, and decreased expression of the Aβ receptor CD36 on microglia. Therefore, ineffective immune regulation by the PD‐1/PD‐L1 axis contributes to Aβ plaque deposition during chronic neuroinflammation in AD. Neuroinflammation, a hallmark of Alzheimer’s disease (AD), is involved in beta‐amyloid peptide (Aβ) plaque deposition and clearance. Here, the PD‐1/PD‐L1 axis is found as an important pathway for regulating the immune system in the brain, sustaining microglial Aβ uptake and reducing chronic neuroinflammation. The immune‐checkpoint receptor/ligand pair PD‐1/PD‐L1 sustains phagocytic function of microglia to prevent Aβ plaque deposition in APP/PS mouse models and patient tissues.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2021108662

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A majority of Alzheimer's disease risk genes identified through genome-wide association studies are highly expressed in microglia, suggesting a key role in microglial dysfunction.

    “A majority of AD risk genes identified through genome-wide association studies are highly expressed in microglia, the brain’s innate immune cells, suggesting a key role in microglial dysfunction (Kummer et al., 2021; Penney et al., 2020; Teipel et al., 2022).”

    From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Kummer et al., 2021

    The Results section ('PD-1 regulates microglial Aβ uptake and inflammation'; page unavailable) links altered microglial gene expression to inflammatory pathways, supporting a role for microglial dysfunction in AD pathology. It does not say that a majority of GWAS-identified AD risk genes are highly expressed in microglia; searches for 'genome-wide association studies' and 'GWAS risk genes' found no such passage. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 55 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kummer, M. P., Ising, C., Kummer, C., Sarlus, H., Griep, A., Vieira‐Saecker, A., Schwartz, S., Halle, A., Brückner, M., Händler, K., Schultze, J. L., Beyer, M., Latz, E., & Heneka, M. T.
Affiliations
  • University of Bonn (DE)
  • German Center for Neurodegenerative Diseases (DE)
  • Center of Advanced European Studies and Research (DE)
Corresponding author
  • Kummer, Markus P
  • Heneka, Michael T
Venue
The EMBO Journal
Published
2021-11-26
Volume
40
Issue
24
Pages
e108662-e108662
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3215791278
Cited by
127
References
55
Citations by year
2026: 22 · 2025: 28 · 2024: 42 · 2023: 24 · 2022: 10 · 2021: 1
FWCI
9.38
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion, other-oa)
Funders
  • European Union Seventh Framework Program (INMIND)
  • Deutsche Forschungsgemeinschaft (KFO177, IS 299/3‐1, EXC2151‐390873048)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
Alzheimer's disease, neuroinflammation, PD-1/PD-L1 axis, microglia, astrocytes, amyloid plaques, amyloid-beta uptake, CD36, APP/PS1 mice, immune checkpoint, phagocytosis, amyloid-beta clearance, ectodomain shedding
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Disease Models, Animal, Female, HeLa Cells, Humans, Male, Mice, Transgenic, Middle Aged, Up-Regulation, Case-Control Studies, Amyloid beta-Protein Precursor, Gene Deletion, Microglia, CD36 Antigens, Mice, HEK293 Cells, B7-H1 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review